Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Schedule Your Follow-Up Regular visits can help monitor your experience and allow adjustments to your wellness routine
PubMed laboratory research record [PMID: 6199523] PubMed record related to this compound for laboratory literature review
In a phase 2 dose-finding trial, once-weekly Cagrilintide produced clinically meaningful weight loss about 10.8% at the 4.5 mg dose over 26 weeks with gastrointestinal effects the most common adverse events [1]
Use our peptide dosage calculator and reconstitution guide for step-by-step instructions tailored to your research dose
Eur J Pharmacol 131:105109, 1986 Sikiric P, Rotkvic I, Mise S, Krizanac S, Gjuris V, Jukic J, Suchanek E, Petek M, Udovicic I, Kalogjera L, Geber J, Tucan-Foretic M, Duvnjak M, Philipp M, Balen I, Anic T: The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats
Boost Your Metabolism & Burn Stubborn Fat with B12 Shots Looking for a safe and effective way to jumpstart your weight loss journey
US$ 21.56
US$ 23.17
US$ 24.45
US$ 20.61
US$ 22.04
US$ 25.32
US$ 26.82
